Connection

Susan Dorman to Mycobacterium tuberculosis

Back to Details
This is a "connection" page, showing publications Susan Dorman has written about Mycobacterium tuberculosis.
Susan Dorman
Connection Strength
12.559
Mycobacterium tuberculosis
  1. Latent Tuberculosis Infection. N Engl J Med. 2021 12 09; 385(24):2271-2280.
    View in: PubMed
    Score: 0.735
  2. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
    View in: PubMed
    Score: 0.705
  3. Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative. Clin Infect Dis. 2018 11 13; 67(11):1653-1659.
    View in: PubMed
    Score: 0.594
  4. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018 01; 18(1):76-84.
    View in: PubMed
    Score: 0.556
  5. Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis. J Clin Microbiol. 2016 Apr; 54(4):1051-7.
    View in: PubMed
    Score: 0.491
  6. Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis. 2015 Jul; 19(7):780-6.
    View in: PubMed
    Score: 0.470
  7. Advances in the diagnosis of tuberculosis: current status and future prospects. Int J Tuberc Lung Dis. 2015 May; 19(5):504-16.
    View in: PubMed
    Score: 0.465
  8. Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. J Clin Microbiol. 2014 Jul; 52(7):2513-20.
    View in: PubMed
    Score: 0.434
  9. Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis. 2013 Jul 29; 13:352.
    View in: PubMed
    Score: 0.412
  10. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLoS One. 2012; 7(8):e43307.
    View in: PubMed
    Score: 0.385
  11. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One. 2012; 7(5):e36551.
    View in: PubMed
    Score: 0.378
  12. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol. 2012 Apr; 50(4):1189-94.
    View in: PubMed
    Score: 0.370
  13. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact. Int J Tuberc Lung Dis. 2011 May; 15(5):628-34.
    View in: PubMed
    Score: 0.352
  14. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis. 2009 Feb 28; 9:23.
    View in: PubMed
    Score: 0.303
  15. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One. 2008; 3(12):e4057.
    View in: PubMed
    Score: 0.300
  16. Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis. J Clin Microbiol. 2008 Nov; 46(11):3811-2.
    View in: PubMed
    Score: 0.294
  17. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007 Oct; 45(10):3387-9.
    View in: PubMed
    Score: 0.272
  18. Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest. 2007 Sep; 132(3):946-51.
    View in: PubMed
    Score: 0.269
  19. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat Med. 2007 Mar; 13(3):295-8.
    View in: PubMed
    Score: 0.264
  20. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007 Mar 01; 44(5):674-80.
    View in: PubMed
    Score: 0.262
  21. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS. 2006 Mar 21; 20(5):751-62.
    View in: PubMed
    Score: 0.247
  22. Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol. 2004 Feb; 6(2):105-16.
    View in: PubMed
    Score: 0.213
  23. Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol. 2003 Mar; 41(3):948-53.
    View in: PubMed
    Score: 0.200
  24. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel. Lancet HIV. 2022 11; 9(11):e791-e800.
    View in: PubMed
    Score: 0.195
  25. Field evaluation of a rapid immunochromatographic test for tuberculosis. J Clin Microbiol. 2002 Jun; 40(6):1989-93.
    View in: PubMed
    Score: 0.190
  26. Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2021 09 17; 65(10):e0179420.
    View in: PubMed
    Score: 0.179
  27. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid. Clin Infect Dis. 2020 08 22; 71(5):1161-1167.
    View in: PubMed
    Score: 0.168
  28. Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infect Dis. 2020 06; 20(6):742-752.
    View in: PubMed
    Score: 0.163
  29. Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis. J Infect Dis. 2019 10 08; 220(220 Suppl 3):S99-S107.
    View in: PubMed
    Score: 0.158
  30. Diagnosis of HIV-associated tuberculosis. Curr Opin HIV AIDS. 2018 11; 13(6):462-468.
    View in: PubMed
    Score: 0.148
  31. Serologic Responses in Childhood Pulmonary Tuberculosis. Pediatr Infect Dis J. 2018 Jan; 37(1):1-9.
    View in: PubMed
    Score: 0.140
  32. Molecular Drug-Susceptibility Test for Tuberculosis. N Engl J Med. 2017 12 14; 377(24):2404.
    View in: PubMed
    Score: 0.139
  33. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. N Engl J Med. 2017 09 14; 377(11):1043-1054.
    View in: PubMed
    Score: 0.137
  34. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis. J Antimicrob Chemother. 2017 08 01; 72(8):2320-2325.
    View in: PubMed
    Score: 0.136
  35. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet. 2017 Mar; 49(3):395-402.
    View in: PubMed
    Score: 0.131
  36. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):853-67.
    View in: PubMed
    Score: 0.128
  37. Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers. Tuberculosis (Edinb). 2016 12; 101S:S83-S91.
    View in: PubMed
    Score: 0.128
  38. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology. PLoS One. 2015; 10(7):e0133756.
    View in: PubMed
    Score: 0.118
  39. Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation. J Clin Microbiol. 2015 Apr; 53(4):1258-63.
    View in: PubMed
    Score: 0.114
  40. Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda. PLoS One. 2014; 9(9):e107595.
    View in: PubMed
    Score: 0.111
  41. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother. 2014; 58(1):11-8.
    View in: PubMed
    Score: 0.104
  42. Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies. BMC Infect Dis. 2013 Sep 03; 13:407.
    View in: PubMed
    Score: 0.104
  43. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis. 2013 Aug; 57(4):532-42.
    View in: PubMed
    Score: 0.102
  44. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. PLoS One. 2012; 7(11):e49898.
    View in: PubMed
    Score: 0.098
  45. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium. J Infect Dis. 2012 Oct 01; 206(7):1030-40.
    View in: PubMed
    Score: 0.096
  46. Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. J Acquir Immune Defic Syndr. 2011 Oct 01; 58(2):219-23.
    View in: PubMed
    Score: 0.091
  47. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant. 2009 Dec; 9 Suppl 4:S57-62.
    View in: PubMed
    Score: 0.080
  48. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009 Aug 01; 180(3):273-80.
    View in: PubMed
    Score: 0.077
  49. Specimen dilution improves sensitivity of the amplified Mycobacterium tuberculosis direct test for smear microscopy-positive respiratory specimens. J Clin Microbiol. 2008 Jan; 46(1):314-6.
    View in: PubMed
    Score: 0.069
  50. Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol. 2004 Jan; 11(1):94-7.
    View in: PubMed
    Score: 0.053
  51. The rapid development of fluoroquinolone resistance in M. tuberculosis. N Engl J Med. 2003 Nov 13; 349(20):1977-8.
    View in: PubMed
    Score: 0.053
  52. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis. 2003 Dec 01; 37(11):1448-52.
    View in: PubMed
    Score: 0.052
  53. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):e147-e195.
    View in: PubMed
    Score: 0.032
  54. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC Infect Dis. 2015 Feb 15; 15:62.
    View in: PubMed
    Score: 0.029
  55. Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil. Int J Tuberc Lung Dis. 2013 Oct; 17(10):1336-40.
    View in: PubMed
    Score: 0.026
  56. Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa. PLoS One. 2011 Apr 11; 6(4):e18358.
    View in: PubMed
    Score: 0.022
  57. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury. Int J Tuberc Lung Dis. 2007 Jul; 11(7):775-80.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.